Mark Rothera Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Rothera.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Rothera. Mark Rothera is Chief Commercial Officer in PTC THERAPEUTICS, INC. ($PTCT) and Global President in Aegerion Pharmaceuticals, Inc. ($AEGR).
Latest Insider Trading Transactions of Mark Rothera
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 2,000 | 21,700 | 6,125 | |
| May 25 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 2,000 | 21,700 | 33,739 | 31.7 K to 33.7 K (+6.30 %) |
| Mar 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 2,966 | 32,181 | 69,227 | |
| Mar 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 2,966 | 32,181 | 31,739 | 28.8 K to 31.7 K (+10.31 %) |
| Feb 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 72,193 | |
| Feb 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 28,773 | 25.6 K to 28.8 K (+12.18 %) |
| Jan 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 75,318 | |
| Jan 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 25,648 | 22.5 K to 25.6 K (+13.87 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | A | 11.23 | 56,000 | 628,880 | 56,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Grant | A | 0.00 | 9,600 | 0 | 22,523 | 12.9 K to 22.5 K (+74.29 %) |
| Nov 14 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,941 | 21,060 | 78,443 | |
| Nov 14 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,941 | 21,060 | 11,216 | 9.3 K to 11.2 K (+20.93 %) |
| Oct 11 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,950 | 21,158 | 80,384 | |
| Oct 11 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,950 | 21,158 | 9,275 | 7.3 K to 9.3 K (+26.62 %) |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 2,200 | 23,870 | 82,334 | |
| Sep 26 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 2,200 | 23,870 | 7,325 | 5.1 K to 7.3 K (+42.93 %) |
| Mar 07 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | P | 6.23 | 2,000 | 12,460 | 5,125 | 3.1 K to 5.1 K (+64.00 %) |
| Jan 15 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 84,534 | |
| Jan 15 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 3,125 | 0 to 3.1 K |
| Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | A | 30.86 | 70,000 | 2,160,200 | 70,000 | |
| Jul 21 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 9,216 | 99,994 | 87,659 | |
| Jul 21 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 9,216 | 99,994 | 9,216 | 0 to 9.2 K |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,250 | 13,563 | 8,125 | |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 9,450 | 102,533 | 96,875 | |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 76.64 | 10,700 | 820,048 | 0 | 10.7 K to 0 (-100.00 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,250 | 13,563 | 10,700 | 9.5 K to 10.7 K (+13.23 %) |
| Mar 18 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 9,450 | 102,533 | 9,450 | 0 to 9.5 K |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 300 | 3,255 | 106,325 | |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 76.36 | 300 | 22,908 | 0 | 300 to 0 (-100.00 %) |
| Mar 13 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 300 | 3,255 | 300 | 0 to 300 |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 625 | 6,781 | 9,375 | |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 10,375 | 112,569 | 106,625 | |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 1,000 | 10,850 | 117,000 | |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 20,000 | 217,000 | 118,000 | |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 73.49 | 11,000 | 808,390 | 0 | 11 K to 0 (-100.00 %) |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 625 | 6,781 | 11,000 | 10.4 K to 11 K (+6.02 %) |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 10,375 | 112,569 | 10,375 | 0 to 10.4 K |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 67.70 | 1,000 | 67,700 | 0 | 1,000 to 0 (-100.00 %) |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 1,000 | 10,850 | 1,000 | 0 to 1,000 |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 67.84 | 10,000 | 678,400 | 0 | 10 K to 0 (-100.00 %) |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 63.66 | 5,000 | 318,300 | 10,000 | 15 K to 10 K (-33.33 %) |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 62.69 | 5,000 | 313,450 | 15,000 | 20 K to 15 K (-25.00 %) |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 20,000 | 217,000 | 20,000 | 0 to 20 K |
| Feb 25 2015 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 64.72 | 3,000 | 194,160 | 0 | 3 K to 0 (-100.00 %) |
| Jun 05 2012 | AEGR | Aegerion Pharmaceu ... | Rothera Mark | Global President | Option Exercise | A | 14.41 | 21,658 | 312,092 | 21,658 | |
| Jun 05 2012 | AEGR | Aegerion Pharmaceu ... | Rothera Mark | Global President | Option Exercise | A | 13.39 | 200,000 | 2,678,000 | 200,000 |
Page: 1